Genovis Investor Relations » Press Releases

April 27, 2022 08:00 (CEST) Interim Report January – March 2022 Regulatory MAR

April 21, 2022 08:00 (CEST) Genovis Annual Report 2021 published Regulatory

April 06, 2022 14:33 (CEST) NOTICE CONVENING THE 2022 ANNUAL GENERAL MEETING Regulatory

February 08, 2022 08:00 (CET) Year-end Report January - December 2021 Regulatory MAR

November 12, 2021 12:00 (CET) INTERIM REPORT FOR July – September 2021 Regulatory MAR

October 21, 2021 14:00 (CEST) Genovis announces exclusive license agreement with Selecta Bioscience to develop and promote a novel IgG Protease in Gene Therapy and Autoimmune Disease Regulatory MAR

October 06, 2021 08:35 (CEST) Genovis AB (publ.) hires new CFO Regulatory

August 12, 2021 08:05 (CEST) HALF-YEAR REPORT FOR THE FIRST HALF OF 2021 Regulatory MAR

June 07, 2021 15:02 (CEST) Genovis and GlycoT Therapeutics enter into cross-licensing agreements on novel antibody conjugation technology

May 20, 2021 11:09 (CEST) Communiqué from Genovis AB (publ) Annual General Meeting May 20, 2021 Regulatory

Press Releases